ZEPP // Zepp Health Corporation each representing sixteen (Class A)
DES <GO> NYSE RQD COCKPIT → CIK 0001720446 ↗Zepp Health Corporation each representing sixteen (Class A) (ZEPP) exhibits 38.3% gross margins and -14.7% return on invested capital within Technology (Computer Manufacturing), balanced against a 24.0x enterprise multiple and 4.8% implied options volatility.
Sustained 38.3% gross profitability converts into -11.3% operating margin and -14.7% ROIC, outpacing sector cost of capital.
ROIC: -14.7% // GM: 38.3%YoY revenue trajectory of +41.8% paired with 2.80% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +41.8% // FCF YLD: 2.80%Altman Z-Score of 0.33 and Piotroski F-Score of 5/9 indicate low near-term refinancing stress.
ALTMAN Z: 0.33 // F-SCORE: 5/9Trading at 24.0x trailing P/E (— Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.0x // EV/EBITDA: —Options market prices a ±5.2% implied move with a 0.85 put/call ratio around $2.25 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Computer Manufacturing require continuous execution to defend -15.5% net margins.
NET MARGIN: -15.5% // D/E: 0.45x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for ZEPP & activate live FRED threshold breach alerts.